This month, AMA Journal of Ethics theme editor Jacquelyn Nestor, a fifth-year MD/PhD student at Hofstra-Northwell School of Medicine, interviewed Allen Buchanan, PhD, about how we can safely explore cutting-edge biomedical enhancements.

A look at Pamela Bjorkland’s critique of the use of psychoactive drugs to improve mood, a practice known as cosmetic psychopharmacology.

Medical ethics concerns about the use of memory-modulating technologies should not override individual decisions about their use in clinical contexts.

A review of three journal articles shows the significant impact that poverty has on physical and mental health status, as well as all causes of mortality.

Concerns about the deleterious effects of stress on the mind and body have led to the beginnings of a stress vaccine, an injection that will reduce these effects.

Neurobiological markers raise complex questions about what it means to be “at risk.”

Neuromodulation has ethical implications for self-identity and public communication of scientific findings.